Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:approvedBy |
gptkb:European_Union
1990s many other countries |
| gptkbp:ATCCode |
gptkb:J07BK01
|
| gptkbp:contains |
live attenuated varicella-zoster virus
|
| gptkbp:contraindication |
pregnancy
immunosuppressed individuals |
| gptkbp:indication |
adolescents
adults children |
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
fever
rash injection site reactions |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
prevention of varicella (chickenpox)
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:varicella_vaccine
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Varilrix
|